Human Anti-CD2 Recombinant Antibody (clone YTH 655) (CAT#: FAMAB-1038CQ)

• Valuable for T-cell Differentiation
  YTH 655 has provided clear insights into how CD2 signaling influences T-cell differentiation. It is an excellent tool for studying the development of distinct T-cell subsets.
• Enhances Cancer Research
  YTH 655 has significantly impacted our cancer research by enabling detailed studies on CD2-mediated T-cell responses against tumors, contributing valuable data for immunotherapy development.
• Specific Antigen Responses
  YTH 655 has been crucial in studying antigen-specific T-cell responses. Its role in understanding how CD2 co-stimulation influences T-cell responses to specific antigens is highly valuable.

1. Q 1: Is YTH 655 useful for researching T-cell responses specific to antigens?

   A: Yes, YTH 655 can be employed along with specific antigens to examine how CD2 co-stimulation affects antigen-specific T-cell activation and responses, valuable for targeted immunotherapy research.

2. Q 2: In what ways does YTH 655 advance our knowledge of T-cell metabolism?

   A: Engaging CD2 with YTH 655 allows for the investigation of metabolic changes in T-cells during activation, highlighting the metabolic pathways necessary for T-cell function and proliferation.

3. Q 3: Is it effective to employ the YTH 655 antibody in FC?

   A: Yes, YTH 655 can be employed in FC to visualize CD2 expression in tissue sections,

View the frequently asked questions answered by Creative Biolabs Support.